Gefitinib: A Selective EGFR Tyrosine Kinase Inhibitor for Targeted...

added blog Health

2026-05-29 07:26:08 -

Gefitinib: A Selective EGFR Tyrosine Kinase Inhibitor for Targeted Lung Cancer Therapy

What Is Gefitinib? Gefitinib is a small molecule, highly selective EGFR tyrosine kinase inhibitor (EGFR-TKI). It is primarily used for the treatment of non-small cell lung cancer (NSCLC) with activating EGFR mutations. Gefitinib functions as an EGFR inhibitor by selectively binding to the ATP-binding site of the EGFR tyrosine kinase domain. This binding prevents the autophosphorylation of...

0 Comments 0 Shares 736 Views 0 Reviews